Frontiers in Pharmacology (May 2023)

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score

  • Jochen G. Mainz,
  • Jochen G. Mainz,
  • Carlos Zagoya,
  • Louise Polte,
  • Lutz Naehrlich,
  • Lutz Naehrlich,
  • Lenny Sasse,
  • Olaf Eickmeier,
  • Christina Smaczny,
  • Anton Barucha,
  • Lilith Bechinger,
  • Franziska Duckstein,
  • Ludwik Kurzidim,
  • Ludwik Kurzidim,
  • Patience Eschenhagen,
  • Laura Caley,
  • Daniel Peckham,
  • Daniel Peckham,
  • Carsten Schwarz

DOI
https://doi.org/10.3389/fphar.2023.1207356
Journal volume & issue
Vol. 14

Abstract

Read online

No abstracts available.

Keywords